…
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Core Laboratories NV provides technical services and products that help oil and gas companies characterize reservoirs, optimize production and enhance recovery through laboratory analyses, well diagnostics and consulting on a global basis. Long-term growth may be supported by persistent energy demand, efforts to maximize recovery from mature fields and periodic increases in upstream capital spending. The company appears positioned with specialized technical expertise, recurring testing services and a broad field footprint that could support steady cash flows.
Key risks include sensitivity to oil and gas capital spending and commodity cycles, client concentration and competition from larger service providers, and longer-term regulatory and demand shifts related to the energy transition that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 45.90M | 46.19M | 41.21M | 29.95M | 36.11M |
| Minority interest | -0.72M | -0.75M | -0.35M | -0.20M | -0.49M |
| Net income | 29.67M | 31.40M | 36.67M | 19.45M | 19.73M |
| Selling general administrative | 44.23M | 38.59M | 40.26M | 38.12M | 44.17M |
| Selling and marketing expenses | - | - | 1.36M | - | - |
| Gross profit | 94.28M | 88.37M | 94.05M | 78.92M | 83.84M |
| Reconciled depreciation | 14.65M | 14.95M | 15.78M | 17.16M | 18.52M |
| Ebit | 56.47M | 58.56M | 54.64M | 41.52M | 45.26M |
| Ebitda | 71.12M | 73.51M | 70.42M | 58.69M | 63.78M |
| Depreciation and amortization | 14.65M | 14.95M | 15.78M | 17.16M | 18.52M |
| Operating income | 50.49M | 58.56M | 54.64M | 41.52M | 45.26M |
| Other operating expenses | 476.03M | 465.29M | 455.15M | 448.21M | 430.58M |
| Interest expense | 10.57M | 12.37M | 13.43M | 11.57M | 9.15M |
| Tax provision | 13.37M | 14.03M | 4.18M | 10.30M | 15.89M |
| Interest income | 10.57M | 12.37M | 13.43M | 11.57M | 9.15M |
| Net interest income | -10.57M | -12.37M | -13.43M | -11.57M | -9.15M |
| Extraordinary items | - | - | - | 0.00M | 0.00M |
| Income tax expense | 15.51M | 14.03M | 4.18M | 10.30M | 15.89M |
| Total revenue | 526.52M | 523.85M | 509.79M | 489.74M | 470.25M |
| Total operating expenses | 43.80M | 29.82M | 39.41M | 37.40M | 44.17M |
| Cost of revenue | 432.24M | 435.48M | 415.74M | 410.82M | 386.41M |
| Total other income expense net | -4.59M | -12.37M | -13.43M | -11.57M | -9.15M |
| Net income from continuing ops | 30.39M | 32.15M | 37.02M | 19.66M | 20.22M |
| Net income applicable to common shares | 31.80M | 31.40M | 36.67M | 19.45M | 19.73M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 584.01M | 590.41M | 586.39M | 578.35M | 580.85M |
| Intangible assets | 7.12M | 6.40M | 6.93M | 7.48M | 8.14M |
| Other current assets | 16.67M | 20.69M | 13.25M | 28.92M | 29.08M |
| Total liab | 311.80M | 332.67M | 356.59M | 389.40M | 419.85M |
| Total stockholder equity | 265.99M | 251.99M | 224.81M | 188.95M | 161.00M |
| Deferred long term liab | - | - | - | 54.69M | 63.44M |
| Other current liab | 51.73M | 31.06M | 32.38M | 39.65M | 40.95M |
| Common stock | 0.47M | 0.47M | 0.47M | 1.19M | 1.19M |
| Capital stock | 0.47M | 0.47M | 0.47M | 1.19M | 1.19M |
| Retained earnings | 172.66M | 150.28M | 120.76M | 85.95M | 68.35M |
| Other liab | - | - | - | 75.57M | 91.15M |
| Good will | 105.79M | 99.44M | 99.44M | 99.44M | 99.44M |
| Other assets | 102.64M | 224.93M | 0.00M | 102.32M | 107.72M |
| Cash | 22.70M | 19.16M | 15.12M | 15.43M | 17.70M |
| Cash and equivalents | 22.85M | 19.16M | - | 15.43M | 17.70M |
| Total current liabilities | 106.02M | 97.59M | 88.10M | 103.14M | 90.78M |
| Current deferred revenue | 5.55M | 9.33M | 4.75M | 5.94M | 7.76M |
| Net debt | 141.32M | 160.99M | 200.26M | 206.96M | 232.56M |
| Short term debt | 11.46M | 10.69M | 10.18M | 11.70M | 12.34M |
| Short long term debt total | 164.02M | 180.14M | 215.38M | 222.39M | 250.26M |
| Other stockholder equity | 98.66M | 107.01M | 108.56M | 105.59M | 101.60M |
| Property plant equipment | 153.79M | 153.55M | - | 157.41M | 172.34M |
| Total current assets | 214.66M | 226.61M | 223.14M | 211.70M | 189.06M |
| Long term investments | 4.43M | 5.08M | 4.84M | 4.45M | 4.16M |
| Net tangible assets | - | - | - | 115.64M | -58.46M |
| Net receivables | 120.80M | 127.36M | 123.07M | 106.91M | 96.83M |
| Long term debt | 110.25M | 126.11M | 163.13M | 172.39M | 188.64M |
| Inventory | 54.50M | 59.40M | 71.70M | 60.45M | 45.44M |
| Accounts payable | 37.27M | 34.55M | 33.51M | 45.85M | 29.73M |
| Noncontrolling interest in consolidated entity | - | - | - | 4.70M | 4.55M |
| Accumulated other comprehensive income | -5.81M | -5.77M | -4.97M | -3.78M | -10.13M |
| Common stock total equity | - | - | - | 1.19M | 1.19M |
| Retained earnings total equity | - | - | - | 85.95M | 68.35M |
| Treasury stock | - | - | - | -1.36M | -4.08M |
| Non currrent assets other | 30.84M | 29.71M | 98.58M | -73.02M | -74.62M |
| Non current assets total | 369.35M | 363.80M | 363.26M | 366.65M | 391.80M |
| Capital lease obligations | 53.77M | 54.03M | 52.25M | 50.00M | 61.63M |
| Long term debt total | 110.25M | 126.11M | - | 172.39M | 188.64M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -6.39M | -6.65M | -3.86M | -10.22M |
| Change to liabilities | - | - | - | 3.64M | 6.57M |
| Total cashflows from investing activities | -2.23M | -6.39M | -6.65M | -3.86M | -10.22M |
| Net borrowings | -15.00M | -38.00M | -9.00M | -17.21M | -71.00M |
| Total cash from financing activities | -31.25M | -45.96M | -18.45M | -23.38M | -22.46M |
| Change to operating activities | - | - | - | -13.63M | -11.37M |
| Net income | 30.39M | 32.15M | 37.02M | 19.66M | 20.22M |
| Change in cash | 3.54M | 4.04M | -0.31M | -2.27M | 3.90M |
| Begin period cash flow | 19.16M | 15.12M | 15.43M | 17.70M | 13.81M |
| End period cash flow | 22.70M | 19.16M | 15.12M | 15.43M | 17.70M |
| Total cash from operating activities | 37.03M | 56.39M | 24.79M | 24.96M | 36.58M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 60.00M |
| Depreciation | 14.65M | 14.95M | 15.78M | 17.16M | 18.52M |
| Other cashflows from investing activities | 13.74M | 6.63M | 3.93M | 6.36M | 2.44M |
| Dividends paid | 1.87M | 1.88M | 1.87M | -1.85M | -1.83M |
| Change to inventory | 2.64M | 9.37M | -12.98M | -14.86M | -4.55M |
| Change to account receivables | -4.95M | -3.61M | -2.62M | -10.08M | -13.52M |
| Sale purchase of stock | -12.43M | -5.31M | -2.20M | -3.90M | -8.26M |
| Other cashflows from financing activities | -1.96M | -0.78M | -5.38M | 113.38M | 153.63M |
| Change to netincome | - | - | - | 12.71M | 9.84M |
| Capital expenditures | 14.74M | 13.03M | 10.58M | 10.22M | 13.54M |
| Change receivables | - | - | - | -10.08M | -13.52M |
| Cash flows other operating | - | - | - | -3.27M | -0.32M |
| Cash and cash equivalents changes | - | - | - | -2.27M | 3.90M |
| Change in working capital | -14.53M | 7.88M | -28.77M | -9.56M | -11.50M |
| Stock based compensation | 7.14M | 3.75M | 13.97M | 7.76M | 19.09M |
| Other non cash items | -2.04M | -3.03M | -2.41M | -10.49M | -15.76M |
| Free cash flow | 22.29M | 43.36M | 14.21M | 14.74M | 23.04M |
Sector: Energy Industry: Oil & Gas Equipment & Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLB Core Laboratories NV |
- -% |
9.04 | 23.58 | 19.76 | 1.08 | 2.06 | 1.35 | 11.22 |
| SLB SLB N.V. |
1.06 2.12% |
50.96 | 26.44 | 16.31 | 2.21 | 3.04 | 2.42 | 13.18 |
| BKR Baker Hughes Co |
1.64 3.43% |
49.41 | 18.24 | 17.57 | 2.03 | 2.83 | 2.05 | 11.20 |
| HAL Halliburton Company |
- -% |
32.93 | 18.29 | 12.12 | 1.33 | 2.65 | 1.58 | 9.83 |
| FTI TechnipFMC PLC |
0.84 1.30% |
65.39 | 25.50 | 21.74 | 2.82 | 8.73 | 2.77 | 14.51 |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
| Name | Title | Year Born |
|---|---|---|
| Mr. Lawrence V. Bruno | Chairman, CEO, Pres & COO | 1960 |
| Mr. Christopher Scott Hill | Sr. VP & CFO | 1970 |
| Ms. Gwendolyn Y. Gresham M.B.A. | Sr. VP of Corp. Devel. & Investor Relations | 1968 |
| Mr. Mark Damian Tattoli | Sr. VP, Sec. & Gen. Counsel | 1972 |
| Mr. Kevin G. Daniels | Chief Accounting Officer, Treasurer & VP | 1964 |
| Mr. Jacobus Schouten | Managing Director | 1955 |
| J. Donald Dumas Jr. | Sr. VP of Production Enhancement & Bus. Devel. | NA |
| Mr. Lawrence V. Bruno | Chairman of the Board, CEO, President & COO | 1959 |
| Mr. Christopher Scott Hill | Senior VP & CFO | 1970 |
| Ms. Gwendolyn Y. Gresham M.B.A. | Senior Vice President of Corporate Development & Investor Relations | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.